Cortechs.ai Highlights Groundbreaking NeuroQuant® ARIA Technology in Anticipation of Growing Market Demand
SAN DIEGO, Nov. 14, 2024 /PRNewswire/ -- As the global leader in advanced MRI post-processing solutions, Cortechs.ai is proud to highlight...
SAN DIEGO, Nov. 14, 2024 /PRNewswire/ -- As the global leader in advanced MRI post-processing solutions, Cortechs.ai is proud to highlight...
LAKE NONA, Fla., Nov. 14, 2024 /PRNewswire/ -- Fountain Life, a longevity, preventative health, advanced diagnostics, and therapeutics company, today...
Athlete-controlled platform solves persistent problems around transparent, portable and accessible health data VANCOUVER, BC, Nov. 14, 2024 /CNW/ - Unify.Health, which...
Sea's novel synthetic molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the central nervous system,...
World's First-Ever Study Tracking Biodistribution of DehydraTECH GLP-1 Molecules KELOWNA, BRITISH COLUMBIA / ACCESSWIRE / November 14, 2024 / Lexaria...
BOSTON and LEUVEN, Belgium, Nov. 14, 2024 /PRNewswire/ -- Why this news will impact the lives of people affected by Alzheimer's...
LISBON, Portugal, Nov. 13, 2024 /PRNewswire/ -- The BHOUT Bag, world's first "punching bag with a brain" developed by Portuguese...
DehydraTECH clinical test article manufacturing has been completed KELOWNA, BC / ACCESSWIRE / November 13, 2024 / Lexaria Bioscience Corp....
Menninger is the only hospital in the U.S. to offer groundbreaking treatment HOUSTON, TX / ACCESSWIRE / November 13, 2024...
Novel Hyperbaric Oxygen Therapy Shows Promise in Treating Combat-Related PTSD in Veterans, lessening symptoms with lifechanging outcomesORLANDO, Fla., Nov. 13,...
Vancouver, British Columbia--(Newsfile Corp. - November 13, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the...
BERLIN and PARIS, Nov. 13, 2024 /PRNewswire/ -- While Generative AI is creating a buzz across industries and remains in the...
CHICAGO, IL / ACCESSWIRE / November 12, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
Educational conference focused on diagnosis, research and treatment of rare neuroimmune disordersPOWELL, OH / ACCESSWIRE / November 12, 2024 /...
November 12, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Regains Compliance For Continued Listing on Nasdaq Biodexa Pharmaceuticals PLC,...
Next Generation Compact TMS System Offers Physicians, Nurse Practitioners, New Easy to Use, Affordable Effective TreatmentMINNEAPOLIS and CARMARTHENSHIRE, United Kingdom,...
On track to report interim data in six-month evaluable patients in ADVANCED-2 trial of TARA-002 in NMIBC in 4Q 2024Expect...
Latest capital raise will accelerate delivery of silicon roadmap to drive next-generation implantable devices for neurological applications LONDON, Nov. 12,...
Collaboration will leverage GE HealthCare’s legacy and scale of imaging innovation and RadNet’s DeepHealth AI-powered clinical and workflow solutions to...
CVN293 was generally well-tolerated in healthy volunteers for up to 14-days of continuous dosingDose-dependent exposure was observed with evidence of...